Immunome (IMNM) Other Non-Current Assets (2019 - 2026)
Immunome's (IMNM) quarterly Other Non-Current Assets came in at $200000.0 in Q1 2026, up 100.0% YoY from $100000.0 in Q1 2025, and down 95.64% on a QoQ basis from $4.6 million in Q4 2025.
Powered by 
Analysis
Immunome (IMNM) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Immunome (IMNM) has 8 years of Other Non-Current Assets data on file, last reported at $200000.0 in Q1 2026.
- Quarterly Other Non-Current Assets rose 100.0% year-over-year to $200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200000.0 (up 100.0% YoY) and the FY2025 annual result came in at $4.6 million, up 3.99% from the prior year.
- Other Non-Current Assets slipped to $200000.0 in Q1 2026, from $4.6 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $4.6 million in Q4 2025 to a low of $100000.0 in Q1 2022.
- A 5-year average of $891941.2 and a median of $100000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets changed 0.0% — and 2025, when it surged 4455.0%.
- Tracing IMNM's Other Non-Current Assets over 5 years: stood at $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then jumped by 4311.0% to $4.4 million in 2024, then rose by 3.99% to $4.6 million in 2025, then slumped by 95.64% to $200000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $200000.0 (Q1 2026), $4.6 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 618.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 42.45 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 109.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 62.96 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Immunome | 3.03 Bn | 2.51 Bn | - | 5.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.42 Mn |
| Mar 31, 2026 | 5.36 Mn |
| Dec 31, 2025 | 4.59 Mn |
| Sep 30, 2025 | 4.56 Mn |
| Jun 30, 2025 | 210,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 4.41 Mn |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 332,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 332,000.00 |
| Sep 30, 2021 | 100,000.00 |